用SitoC7A修饰的脂质纳米颗粒用于集成的mRNA输送和有针对性的STING激活
Lijie Qiao1, Na Fan1, Yupei Zhang2
1Department of Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
概括
这项研究引入了一种用于mRNA疫苗的新型脂质纳米粒子 (LNP). 工程LNP通过改善传递和向特定免疫细胞来增强抗原表达和免疫反应,从而提高疫苗的疗效.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 使者RNA (mRNA) 疫苗的有效性取决于优化抗原表达和调节免疫激活的有效传递系统.
- 传统的辅助剂可以诱导I型干扰素,这可能会抑制mRNA翻译并降低疫苗的有效性.
- 需要先进的传递系统来增强mRNA表达并精确控制免疫反应.
研究的目的:
- 设计一种多功能脂质纳米粒子 (LNP),克服mRNA疫苗输送中常规辅助剂的局限性.
- 设计一种能增强mRNA翻译并特别激活免疫细胞而不会引起系统性干扰素反应的LNP.
- 为下一代mRNA疫苗创造一个多功能平台,以提高效率.
主要方法:
- 通过将胆固醇替换为通过二硫化键连接的固醇-STING激动剂结合物 (SitoC7A) 来设计了一种新型的脂质纳米粒子 (LNP).
- 研究了SitoC7A在增强树突细胞 (DC) 的LNP吸收和促进mRNA转化方面的双重作用.
- 评估了DCs中的选择性STING信号激活及其对免疫反应的影响.
- 在使用SARS-CoV-2 mRNA和瘤抗原的小鼠模型中评估了SitoC7A-LNPs的疗效.
主要成果:
- 在SitoC7A中的二硫化键增强了DCs对LNP的吸收,并改善了mRNA的翻译.
- C7A部分选择性地触发了DC中的STING信号,避免了系统性干扰素的产生.
- 工程LNP促进了强大的DC成熟和优越的抗原呈现.
- 封装SARS-CoV-2mRNA的SitoC7A-LNPs在小鼠中诱导了强大的保护性免疫力.
- 载有瘤抗原的LNP显著抑制了淋巴瘤进展.
结论:
- 引入了一种新的LNP设计原则,利用单一的工程脂质进行结构支持,增强mRNA传递和向辅助性.
- 这种多功能LNP平台为开发下一代mRNA疫苗提供了一种多功能方法,其强度和有效性得到了提高.
- 该策略有效平衡抗原表达和受控的免疫激活,以提高疫苗的性能.
相关概念视频
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K


